Lv7
3440 积分 2023-12-05 加入
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
15天前
已完结
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
15天前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
18天前
已完结
Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case study
20天前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
3个月前
已完结
Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial
3个月前
已完结
Comparison of Obinutuzumab and Rituximab for Treating Primary Membranous Nephropathy
3个月前
已完结
利妥昔单抗在膜性肾病中应用的专家共识
3个月前
已完结
皖公网安备34019202002308
